187 related articles for article (PubMed ID: 37842281)
1. Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse.
Swartz JA; Franceschini D; Scamperle K
AIMS Public Health; 2023; 10(3):658-677. PubMed ID: 37842281
[TBL] [Abstract][Full Text] [Related]
2. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
[TBL] [Abstract][Full Text] [Related]
3. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496
[TBL] [Abstract][Full Text] [Related]
4. Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US.
Han B; Jones CM; Einstein EB; Compton WM
JAMA Netw Open; 2021 Oct; 4(10):e2129409. PubMed ID: 34652446
[TBL] [Abstract][Full Text] [Related]
5. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
[TBL] [Abstract][Full Text] [Related]
6. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J
J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355
[TBL] [Abstract][Full Text] [Related]
7. Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk.
Tardelli V; Xu KY; Bisaga A; Levin FR; Fidalgo TM; Grucza RA
BMJ Ment Health; 2023 Jul; 26(1):. PubMed ID: 37500184
[TBL] [Abstract][Full Text] [Related]
8. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
[TBL] [Abstract][Full Text] [Related]
9. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder.
Subramaniam GA; Stitzer MA
Drug Alcohol Depend; 2009 Apr; 101(1-2):13-9. PubMed ID: 19081205
[TBL] [Abstract][Full Text] [Related]
11. State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees.
Lindner SR; Hart K; Manibusan B; McCarty D; McConnell KJ
JAMA Health Forum; 2023 Jun; 4(6):e231574. PubMed ID: 37351873
[TBL] [Abstract][Full Text] [Related]
12. Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study.
Hudgins JD; Porter JJ; Monuteaux MC; Bourgeois FT
PLoS Med; 2019 Nov; 16(11):e1002922. PubMed ID: 31689290
[TBL] [Abstract][Full Text] [Related]
13. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
14. Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries.
Friedman S; Patel K; Liu Y; Hartzell S; Keller MS
Subst Use Misuse; 2020; 55(14):2314-2320. PubMed ID: 32835582
[TBL] [Abstract][Full Text] [Related]
15. The cost of opioid use disorder-related conditions in Medicare.
Mark TL; Parish WJ; Weber EM; Steinberg DG; Henretty K
Drug Alcohol Depend; 2023 Mar; 244():109778. PubMed ID: 36701935
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in Prescription Opioid Pain Reliever Misuse Across Age Groups: 2015-2017 National Survey on Drug Use and Health.
Schuler MS; Dick AW; Stein BD
J Gen Intern Med; 2020 Mar; 35(3):792-799. PubMed ID: 31792871
[TBL] [Abstract][Full Text] [Related]
17. Co-occurring substance use and mental disorders among adults with opioid use disorder.
Jones CM; McCance-Katz EF
Drug Alcohol Depend; 2019 Apr; 197():78-82. PubMed ID: 30784952
[TBL] [Abstract][Full Text] [Related]
18. Correlates of Prescription Opioid Use, Misuse, Use Disorders, and Motivations for Misuse Among US Adults.
Han B; Compton WM; Blanco C; Jones CM
J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30153405
[TBL] [Abstract][Full Text] [Related]
19. Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression.
Vekaria V; Bose B; Murphy SM; Avery J; Alexopoulos G; Pathak J
Transl Psychiatry; 2021 May; 11(1):265. PubMed ID: 33941761
[TBL] [Abstract][Full Text] [Related]
20. Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey.
Novak P; Feder KA; Ali MM; Chen J
J Subst Abuse Treat; 2019 Mar; 98():47-52. PubMed ID: 30665603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
